Dr. Bijan Dey will be editing a special issue of the journal Life
Dr. Bijan Dey will be editing a special issue of the journal Life on "Non-coding RNAs in Cellular Differentiation, Development and Diseases". Submit your manuscript by December 31, 2021.
Newest publication from the Dey and Lednev Labs
Using Deep Ultraviolet Resonance Raman Spectroscopy to discriminate between stages of myoblast cell differentiation.
Bijan Dey, University at Albany – Duchene Muscular Dystrophy Testing Methods
Academic Minute - On University at Albany Week: Early detection is critical for combating Duchenne muscular dystrophy. Bijan Dey, principal investigator at the RNA Institute, looks into better testing methods.
RNA Scientists Advance Early Detection of Duchene Muscular Dystrophy
The devastating effects of Duchene muscular dystrophy (DMD) can be mitigated if detection takes place in early childhood. Sadly, early diagnosis is rare. Now, University RNA researchers have discovered a novel method that could solve this long-standing problem. The research team, from the UAlbany laboratories Professor Igor Lednev of Chemistry and Bijan Dey —a principal investigator of the RNA Institute and an associate faculty member of Biological Sciences, respectively— published its findings on July 16 in the journal Nature Scientific Reports.
Researchers' Newly Discovered Biostability in DNA Structures May Lead to Enhanced Therapeutics
A tremendous potential for biomedical applications, including targeted delivery of drugs, exists through DNA nanostructures, but one key challenge has been the limited stability of these structures in the body’s tissues and blood.
New “miRacles” for Human Health
Two RNA Institute scientists produce a nanotechnology approach that detects disease biomarkers at lower cost.
New Therapies Being Developed for Children with Muscular Dystrophy Are Offering Hope
Dey, a faculty researcher at The RNA Institute at the University at Albany, was recently awarded the American Heart Association’s (AHA) prestigious Scientist Development Grant to gain a better understanding of DMD and develop RNA-based therapy treatments that can potentially fight the disease.
Heart Association Awards Grant to University Scientist for Development of New Duchenne Therapies
The American Heart Association (AHA) has awarded its distinguished Scientist Development Grant to a University at Albany researcher for the development of new therapies to treat Duchenne muscular dystrophy (DMD). Bijan K. Dey, PhD, is a faculty researcher at the university’s RNA Institute and is working on a class of small non-coding RNA molecules called microRNAs. His lab is studying how microRNAs maintain normal muscle function and what goes wrong when children are diagnosed with Duchenne MD and associated heart conditions.